6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Original text

Rate this translation

Your feedback will be used to help improve Google Translate

Latest Press Releases

Time	Headline
27m ago	Sunrun Prices $584 million Securitization of Residential Solar and Storage Assets
28m ago	Madison Air Schedules First Quarter 2026 Earnings Conference Call and Webcast
51m ago	Ultra Clean Announces Retirement of the Chief Financial Officer Sheri Savage
51m ago	GridAI Technologies Corp. Announces Receipt of NASDAQ Notice Regarding Late Form 10-K Filing
52m ago	Rush Enterprises, Inc. Reports First Quarter 2026 Results, Announces $0.19 Per Share Dividend

About

Galmed Pharmaceuticals Ltd (NASDAQ:GLMD) — investor relations, events, news, and company updates on 6ix.

Latest News

Galmed Announces a Collaboration Agreement with Tel Aviv University to Evaluate its SCD1 inhibitor, Aramchol, as a Targeted Therapy for Metastatic Brain Cancers

Galmed Announces the Breakthrough Development of a Brain Penetrating New Formulation of its SCD1 inhibitor, Aramchol

Galmed Pharmaceuticals Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2025

Galmed Pharmaceuticals Announces Receipt of Nasdaq Minimum Bid Price Notification

Galmed Announces Acceptance of a Late-Breaking Abstract to be Presented at HEP-DART 2025 Meeting

Financials

Revenue

$0

Market Cap

$3.55 M

EPS

-2.39

Community Chat

Ask AI